QHSLab Inc. Stock Analysis USAQ
QHSLab, Inc. operates as a medical device technology and software as a service company. The company is headquartered in West Palm Beach, Florida and currently employs 12 full-time employees. The company went IPO on 2002-01-09. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. The company also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The firm sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Read More QHSLab Inc (USAQ) Chart
Key Statistics of QHSLab Inc (USAQ)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.53Volume
10.10KP/E Ratio (TTM)
18.0852 Week Range
Market Cap
8.87MAvg. Volume
2908.75Dividend Yield
-Financial Metrics & Statements of QHSLab Inc (USAQ)
FAQ's for QHSLab Inc (USAQ)
- According to Musaffa’s Shariah screening methodology, QHSLab Inc (USAQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.